You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: December 3, 2023

Cephalexin - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for cephalexin and what is the scope of freedom to operate?

Cephalexin is the generic ingredient in five branded drugs marketed by Alkem Labs Ltd, Anda Repository, Apothecon, Aurobindo Pharma, Barr, Belcher Pharms, Chartwell Rx, Facta Farma, Hikma, Ivax Sub Teva Pharms, Lupin, Purepac Pharm, Stevens J, Sun Pharm Inds (in), Sun Pharm Inds Ltd, Teva, Yoshitomi, Pragma, Hikma Pharms, Vitarine, Yung Shin Pharm, Ranbaxy Labs Ltd, and Lilly, and is included in fifty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for cephalexin. Thirty-five suppliers are listed for this compound.

Drug Prices for cephalexin

See drug prices for cephalexin

Drug Sales Revenue Trends for cephalexin

See drug sales revenues for cephalexin

Recent Clinical Trials for cephalexin

Identify potential brand extensions & 505(b)(2) entrants

Network of Canadian Emergency Researchers (NCER)Phase 4
Western Sydney Local Health DistrictPhase 2
Centre Of Research Excellence in Tuberculosis ControlPhase 2

See all cephalexin clinical trials

Pharmacology for cephalexin
Medical Subject Heading (MeSH) Categories for cephalexin

US Patents and Regulatory Information for cephalexin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Facta Farma CEPHALEXIN cephalexin FOR SUSPENSION;ORAL 062117-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Lupin CEPHALEXIN cephalexin CAPSULE;ORAL 065229-002 Nov 25, 2005 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ranbaxy Labs Ltd PANIXINE DISPERDOSE cephalexin TABLET, FOR SUSPENSION;ORAL 065100-002 Sep 11, 2003 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx CEPHALEXIN cephalexin FOR SUSPENSION;ORAL 065326-002 Jul 10, 2006 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Anda Repository CEPHALEXIN cephalexin CAPSULE;ORAL 065248-001 Jun 28, 2005 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pragma KEFLEX cephalexin FOR SUSPENSION;ORAL 050406-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.